|
|
|
|
LEADER |
04003nma a2200997 u 4500 |
001 |
EB002158463 |
003 |
EBX01000000000000001296578 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
230515 ||| eng |
020 |
|
|
|a 9783036570082
|
020 |
|
|
|a 9783036570099
|
020 |
|
|
|a books978-3-0365-7009-9
|
100 |
1 |
|
|a García-Vaquero, Marco
|
245 |
0 |
0 |
|a Novel Applications and Technologies for the Industrial Exploitation of Algal Derived Marine Bioactives as Nutraceuticals or Pharmaceuticals
|h Elektronische Ressource
|
260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
300 |
|
|
|a 1 electronic resource (170 p.)
|
653 |
|
|
|a antioxidant
|
653 |
|
|
|a Sargassum fusiforme polysaccharides
|
653 |
|
|
|a toxicity
|
653 |
|
|
|a seasonal variations
|
653 |
|
|
|a microalgal production
|
653 |
|
|
|a marine biome
|
653 |
|
|
|a environmental tolerance
|
653 |
|
|
|a in silico
|
653 |
|
|
|a n/a
|
653 |
|
|
|a fatty acids
|
653 |
|
|
|a nutraceuticals
|
653 |
|
|
|a Ehrlich ascites carcinoma
|
653 |
|
|
|a therapeutic attributes
|
653 |
|
|
|a anti-cancer
|
653 |
|
|
|a innovative technology
|
653 |
|
|
|a recombinant proteins
|
653 |
|
|
|a algae
|
653 |
|
|
|a adaptive laboratory evolution
|
653 |
|
|
|a marine bioactive peptides
|
653 |
|
|
|a extraction
|
653 |
|
|
|a midkine
|
653 |
|
|
|a Hypnea musciformis
|
653 |
|
|
|a 16S rRNA gene sequencing
|
653 |
|
|
|a MCF-7
|
653 |
|
|
|a LC-ESI-HRMS
|
653 |
|
|
|a microwave-assisted extraction
|
653 |
|
|
|a high-fat diet
|
653 |
|
|
|a Cystoseira compressa
|
653 |
|
|
|a fecal microbiota
|
653 |
|
|
|a natural resources
|
653 |
|
|
|a bioactivities
|
653 |
|
|
|a biotechnology
|
653 |
|
|
|a viral vectors
|
653 |
|
|
|a apoptosis
|
653 |
|
|
|a biopharmaceuticals
|
653 |
|
|
|a VEGF-B
|
653 |
|
|
|a transient expression
|
653 |
|
|
|a in vitro
|
653 |
|
|
|a seaweed
|
653 |
|
|
|a green extraction
|
653 |
|
|
|a anti-hypertensive
|
653 |
|
|
|a biomedical
|
653 |
|
|
|a polyphenol
|
653 |
|
|
|a ceramides
|
653 |
|
|
|a Manufacturing industries / bicssc
|
653 |
|
|
|a p53
|
653 |
|
|
|a pharmacology
|
653 |
|
|
|a biological activity
|
653 |
|
|
|a in vivo
|
653 |
|
|
|a cecal microbiota
|
653 |
|
|
|a Medicine and Nursing / bicssc
|
653 |
|
|
|a TNF-α
|
653 |
|
|
|a fucosterol
|
653 |
|
|
|a cryptides
|
700 |
1 |
|
|a Tiwari, Brijesh K.
|
700 |
1 |
|
|a García-Vaquero, Marco
|
700 |
1 |
|
|a Tiwari, Brijesh K.
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
028 |
5 |
0 |
|a 10.3390/books978-3-0365-7009-9
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/98971
|z DOAB: description of the publication
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/7031
|7 0
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 363
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 615
|
082 |
0 |
|
|a 576
|
082 |
0 |
|
|a 600
|
520 |
|
|
|a The active molecules or bioactives (i.e., polysaccharides, fatty acids, proteins, polyphenols, diterpenes, steroids and alkaloids) from algae (seaweed and microalgae) have been widely studied in recent years for multiple pharmaceutical and nutraceutical applications. Innovative and emerging technologies, including but not limited to ultrasounds, microwaves, electric fields, high-pressure supercritical fluids, ionic fluids and plasma, are currently being explored throughout multiple stages of the pre-treatment, extraction, isolation/purification and preservation of biomolecules from algae. This Special Issue will target research papers, reviews, short communications and perspectives on the use of novel technologies for the pre-treatment, extraction, isolation‒purification, characterization and preservation of marine compounds from algae. It will particularly focus on novel research related to algal bioactives with clear and demonstrated industrial applications and focuses.
|